Q32 Bio Inc. · NASDAQ:QTTB
BVF PARTNERS L P/IL reported a 9.99% stake in Q32 Bio Inc. (Schedule 13G)
Event May 28, 2026 · Filed Jun 4, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Q32 Bio Inc., 2,367,524 shares, as a passive investor on May 28, 2026. Filed Jun 4, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 2,367,524
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.30% | 1,248,973 |
| BVF I GP LLC | 5.30% | 1,248,973 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.90% | 929,003 |
| BVF II GP LLC | 3.90% | 929,003 |
| Biotechnology Value Trading Fund OS LP | 0.70% | 155,156 |
| BVF Partners OS Ltd. | 0.70% | 155,156 |
| BVF GP HOLDINGS LLC | 9.20% | 2,177,976 |
| BVF PARTNERS L P/IL | 9.99% | 2,367,524 |
| BVF INC/IL | 9.99% | 2,367,524 |
| LAMPERT MARK N | 9.99% | 2,367,524 |
Source
Related
- Q32 Bio Inc.
- Bvf Partners L P
- Q32 Bio Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Nov 16, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 16, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Nov 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G/A · Opaleye Management Inc. · Nov 6, 2026
- Schedule 13G/A · Boxer Capital Management, LLC · Nov 6, 2026